Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
108.38
(
0.85%
)
Bitcoin
76,781.99
(
-0.81%
)
News Focus
News Focus
Post# of 3757
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Friday, 10/05/2007 1:53:42 AM

Friday, October 05, 2007 1:53:42 AM

Post# of 3757
A three-minute portion of GILD’s UBS webcast (starting at 19:00) is worth hearing for the discussion of the HBV market. It was noted that e- patients with no evidence of abnormal liver enzymes and no cirrhosis are nonetheless at great risk for liver cancer, and this represents one of the major untapped patient pools for HBV treatment.

http://events.streamx.us/us/Event/PresentationList.aspx?id=46

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote